InsiderFlow

LRMR

Larimar Therapeutics, Inc.$2.98-0.04 (-1.32%)
Prev Close$3.02·MCap$313.7M·P/E—·Vol2.10M·Yield—
▲

Buys (12M)

12

$26.10M

▼

Sells (12M)

0

$0.00

◆

Net Activity

Net Buyer

$26.10M

●

Active Insiders

9

last 12 mo

Over the past 12 months, insider activity at Larimar Therapeutics, Inc. (LRMR) has been exclusively buying, with 12 insider purchases totaling $26.10M and 0 insider sales totaling $0.00. The most recent insider transaction was by BEN-MAIMON CAROLE (director, officer: President and CEO), who purchased $50.0K worth of shares on Nov 12, 2026. Larimar Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $313.7M.

LRMR Insider Trading Activity

DateInsiderTypeValue
Nov 12, 2026 BEN-MAIMON CAROLEBuy$50.0K
Nov 12, 2026 Truitt JosephBuy$9.8K
Nov 12, 2026 Harlow John B. Jr.Buy$49.9K
Nov 12, 2026 Celano MichaelBuy$50.0K
Nov 12, 2026 THOMAS FRANK EBuy$21.8K
Nov 12, 2026 Hamilton Thomas EdwardBuy$187.1K
Nov 12, 2026 Shankar GopiBuy$13.5K
Jul 8, 2026 Hamilton Thomas EdwardBuy$166.9K
Mar 2, 2026 Flynn James EBuy$25.00M5.8% OS
Mar 2, 2026 SHERMAN JEFFREY WBuy$25.0K
Mar 2, 2026 THOMAS FRANK EBuy$25.0K
Mar 2, 2026 Hamilton Thomas EdwardBuy$500.0K
Jul 31, 2025 Flynn James EBuy$30.00M11.0% OS
May 31, 2024 Hamilton Thomas EdwardBuy$500.0K
Feb 16, 2024 Flynn James EBuy$25.00M3.3% OS
Feb 15, 2024 THOMAS FRANK EBuy$22.0K
Dec 8, 2023 Shankar GopiBuy$18.7K
May 18, 2023 BEN-MAIMON CAROLEBuy$18.5K
May 18, 2023 Celano MichaelBuy$18.6K
May 18, 2023 Truitt JosephBuy$10.3K
Sep 20, 2022 Flynn James EBuy$8.75M3.2% OS
Sep 20, 2022 Hamilton Thomas EdwardBuy$1000.0K
Sep 19, 2022 BEN-MAIMON CAROLEBuy$100.0K
Sep 19, 2022 Celano MichaelBuy$100.0K
Jul 2, 2021 Flynn James EBuy$6.00M0.8% OS
Jul 2, 2021 Hamilton Thomas EdwardBuy$496.2K

LRMR Insider Buying Activity

The following table shows recent insider purchases of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 12, 2026 BEN-MAIMON CAROLEBuy$50.0K
Nov 12, 2026 Truitt JosephBuy$9.8K
Nov 12, 2026 Harlow John B. Jr.Buy$49.9K
Nov 12, 2026 Celano MichaelBuy$50.0K
Nov 12, 2026 THOMAS FRANK EBuy$21.8K
Nov 12, 2026 Hamilton Thomas EdwardBuy$187.1K
Nov 12, 2026 Shankar GopiBuy$13.5K
Jul 8, 2026 Hamilton Thomas EdwardBuy$166.9K
Mar 2, 2026 Flynn James EBuy$25.00M5.8% OS
Mar 2, 2026 SHERMAN JEFFREY WBuy$25.0K
Mar 2, 2026 THOMAS FRANK EBuy$25.0K
Mar 2, 2026 Hamilton Thomas EdwardBuy$500.0K
Jul 31, 2025 Flynn James EBuy$30.00M11.0% OS
May 31, 2024 Hamilton Thomas EdwardBuy$500.0K
Feb 16, 2024 Flynn James EBuy$25.00M3.3% OS
Feb 15, 2024 THOMAS FRANK EBuy$22.0K
Dec 8, 2023 Shankar GopiBuy$18.7K
May 18, 2023 BEN-MAIMON CAROLEBuy$18.5K
May 18, 2023 Celano MichaelBuy$18.6K
May 18, 2023 Truitt JosephBuy$10.3K
Sep 20, 2022 Flynn James EBuy$8.75M3.2% OS
Sep 20, 2022 Hamilton Thomas EdwardBuy$1000.0K
Sep 19, 2022 BEN-MAIMON CAROLEBuy$100.0K
Sep 19, 2022 Celano MichaelBuy$100.0K
Jul 2, 2021 Flynn James EBuy$6.00M0.8% OS
Jul 2, 2021 Hamilton Thomas EdwardBuy$496.2K

LRMR Insider Selling Activity

The following table shows recent insider sales of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.

No insider selling activity found for LRMR in the last 12 months.

LRMR Insiders

BEN-MAIMON CAROLE

President and CEO

Bought $168.5K
3 tradesLast: Nov 12, 2026
THOMAS FRANK E

Director

Bought $68.8K
3 tradesLast: Nov 12, 2026
Harlow John B. Jr.

officer: President and COO

Bought $49.9K
1 tradesLast: Nov 12, 2026
Hamilton Thomas Edward

Director

Bought $2.85M
6 tradesLast: Nov 12, 2026
Shankar Gopi

officer: Chief Development Officer

Bought $32.2K
2 tradesLast: Nov 12, 2026
Celano Michael

officer: Chief Financial Officer

Bought $168.6K
3 tradesLast: Nov 12, 2026
Truitt Joseph

Director

Bought $20.0K
2 tradesLast: Nov 12, 2026
Flynn James E

director, 10 percent owner, other: * Director by Deputization

Bought $94.75M
5 tradesLast: Mar 2, 2026
SHERMAN JEFFREY W

director

Bought $25.0K
1 tradesLast: Mar 2, 2026